Magazine articles list

Professor Bruce Morland is a recently retired paediatric oncologist from Birmingham Children’s Hospital. Here, he tells us about his work as a chief investigator on a global clinical trial.

Carrie Wright’s daughter, Lucy, was diagnosed with neuroblastoma in August 2018. She writes on participating in the international MiNivAN clinical trial and offers advice to others faced with making decisions about their child’s treatment.

Katy Jones' daughter Eden was three years old when she was diagnosed with leukaemia in July 2017. She explains some of the things her family considered before deciding on entering into a clinical trial.

Jane Cooper, Rebekah Lewis and Rosie Williams. Research Nurses at Birmingham Children's Hospital (BCH)

Helen Pearson and Katie Johnson, co-chairs of the National Neuroblastoma Nursing Group (NNNG), tell us more about how they have developed a range of animation videos to help parents make decisions about their child’s treatment as part of a neuroblastoma clinical trial

Dr Guy Makin, Senior Lecturer in Paediatric Oncology at the University of Manchester and Honorary Consultant Paediatric Oncologist at Royal Manchester Children’s Hospital, talks to us about his work.

Complementary therapies can play a part in supporting children and teenagers through treatment by offering relaxation and calmness. They are typically used alongside a patient’s standard medical treatment and though they do not treat or cure cancer, they can offer relief from symptoms and help promote feelings or emotional or physical wellbeing.

Dr Amandeep Samrai, Consultant Clinical Psychologist in Paediatric Oncology at Nottingham Children’s Hospital, writes on the impact that a childhood cancer diagnosis can have on emotional health and wellbeing. She offers tips on self-care and coping strategies, and explains where to access support.

Kate Beddow uses types of complementary therapies such as Reiki and journalling to help the wellbeing of families affected by childhood cancer. Here, she tells us more.